Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 122

1.

Current understanding of HIV-associated neurocognitive disorders pathogenesis.

Gannon P, Khan MZ, Kolson DL.

Curr Opin Neurol. 2011 Jun;24(3):275-83. doi: 10.1097/WCO.0b013e32834695fb. Review.

2.

Chronic inflammation and the role for cofactors (hepatitis C, drug abuse, antiretroviral drug toxicity, aging) in HAND persistence.

Gill AJ, Kolson DL.

Curr HIV/AIDS Rep. 2014 Sep;11(3):325-35. doi: 10.1007/s11904-014-0210-3. Review.

3.

HIV-associated neurological disorders: a guide to pharmacotherapy.

Tan IL, McArthur JC.

CNS Drugs. 2012 Feb 1;26(2):123-34. doi: 10.2165/11597770-000000000-00000. Review.

PMID:
22201342
4.

HIV, antiretroviral therapies, and the brain.

Liner KJ 2nd, Ro MJ, Robertson KR.

Curr HIV/AIDS Rep. 2010 May;7(2):85-91. doi: 10.1007/s11904-010-0042-8. Review.

PMID:
20425562
5.

Neuropathogenesis of HIV-associated neurocognitive disorders: roles for immune activation, HIV blipping and viral tropism.

Chen MF, Gill AJ, Kolson DL.

Curr Opin HIV AIDS. 2014 Nov;9(6):559-64. doi: 10.1097/COH.0000000000000105. Review.

6.

Pathogenesis of HIV in the central nervous system.

Valcour V, Sithinamsuwan P, Letendre S, Ances B.

Curr HIV/AIDS Rep. 2011 Mar;8(1):54-61. doi: 10.1007/s11904-010-0070-4. Review.

7.

HIV-1 Induced CNS Dysfunction: Current Overview and Research Priorities.

Joseph J, Colosi DA, Rao VR.

Curr HIV Res. 2016;14(5):389-399. Review.

PMID:
27009096
9.

HIV-associated neurocognitive disorders: perspective on management strategies.

Nabha L, Duong L, Timpone J.

Drugs. 2013 Jun;73(9):893-905. doi: 10.1007/s40265-013-0059-6. Review.

10.

Multiple Faceted Roles of Cocaine in Potentiation of HAND.

Cai Y, Yang L, Callen S, Buch S.

Curr HIV Res. 2016;14(5):412-416. Review.

PMID:
27009095
11.

HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment.

Chan P, Brew BJ.

Curr HIV/AIDS Rep. 2014 Sep;11(3):317-24. doi: 10.1007/s11904-014-0221-0. Review.

PMID:
24966139
12.

Neurobiology of HIV.

Hult B, Chana G, Masliah E, Everall I.

Int Rev Psychiatry. 2008 Feb;20(1):3-13. doi: 10.1080/09540260701862086. Review.

PMID:
18240058
13.

CROI 2014: Neurologic complications of HIV infection.

Spudich SS.

Top Antivir Med. 2014 May;22(2):594-601. Review.

14.

Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction.

Nath A.

Ann N Y Acad Sci. 2010 Feb;1187:122-8. doi: 10.1111/j.1749-6632.2009.05277.x. Review.

PMID:
20201849
15.

HIV-1 infection and neurocognitive impairment in the current era.

del Palacio M, Alvarez S, Muñoz-Fernández MÁ.

Rev Med Virol. 2012 Jan;22(1):33-45. doi: 10.1002/rmv.711. Epub 2011 Sep 23. Review.

PMID:
21990255
16.
17.

Neurological disease: the effects of HIV and antiretroviral therapy and the implications for early antiretroviral therapy initiation.

Wright EJ.

Curr Opin HIV AIDS. 2009 Sep;4(5):447-52. doi: 10.1097/COH.0b013e32832dd0c2. Review.

PMID:
20048710
18.

Neuropathogenesis of HIV: from initial neuroinvasion to HIV-associated neurocognitive disorder (HAND).

Zayyad Z, Spudich S.

Curr HIV/AIDS Rep. 2015 Mar;12(1):16-24. doi: 10.1007/s11904-014-0255-3. Review.

19.

Cells of the central nervous system as targets and reservoirs of the human immunodeficiency virus.

Kramer-Hämmerle S, Rothenaigner I, Wolff H, Bell JE, Brack-Werner R.

Virus Res. 2005 Aug;111(2):194-213. Review.

PMID:
15885841
20.

Treating HIV Infection in the Central Nervous System.

Calcagno A, Di Perri G, Bonora S.

Drugs. 2017 Feb;77(2):145-157. doi: 10.1007/s40265-016-0678-9. Review.

PMID:
28070871

Supplemental Content

Support Center